Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30707397 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL9181053 | 0.96 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL1838148 | 0.88 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL20873232 | 0.86 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL1835622 | 0.85 | CYP1A2 (0.41) | ALDH1A1L3MBTL1MAPTNPSR1TDP1 | |
| SCHEMBL30023141 | 0.84 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL1837899 | 0.84 | CYP1A2 (0.51) | ALDH1A1L3MBTL1MAPTTDP1CYP3A4 | |
| SCHEMBL15417591 | 0.84 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL30171081 | 0.82 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1GLAMAPTNPSR1 | |
| SCHEMBL10382309 | 0.81 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1GLAMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321244-B1 | IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| US-8558030-B2 | Process for telomerization of butadiene | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-10-15 | — | — | US | disclosed |
| US-20110137086-A1 | PROCESS FOR TELOMERIZATION OF BUTADIENE | Dow Global Technologies LLC (Formerly known as Dow Global Technologies Inc.) (US) | 2011-06-09 | — | — | US | disclosed |
| EP-2321244-A2 | AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | Dow Global Technologies LLC (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010019360-A2 | AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-02-18 | — | — | WO | disclosed |
| EP-0479541-B1 | Iridium-optically active phosphine complex and catalytic production of optically active alcohols therewith | TAKASAGO PERFUMERY CO LTD (JP) | 1995-07-19 | — | — | EP | disclosed |
| US-5210332-A | Iridium-optically active phosphine complex and process for producing optically active alcohols using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0479541-A1 | Iridium-optically active phosphine complex and catalytic production of optically active alcohols therewith | Takasago International Corporation (JP) | 1992-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137086-A1 | PROCESS FOR TELOMERIZATION OF BUTADIENE | HRH3, HRH4, TELO2 | ALDH1A1 2964/4885L3MBTL1 4153/4885GLA 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.